Brief: Vincerx Pharma Reports Third Quarter 2022 Financial Results And Provides A Corporate Update
10/11/2022 22:03
Nov 10 (Reuters) - Vincerx Pharma Inc VINC.O :
* VINCERX PHARMA REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES A CORPORATE UPDATE
* VINCERX PHARMA HAD APPROXIMATELY $66.0 MILLION IN CASH,
CASH
EQUIVALENTS AND MARKETABLE SECURITIES AS OF SEPTEMBER 30, 2022
* QTRLY NET LOSS OF APPROXIMATELY $16.9 MILLION, OR $0.80
PER
SHARE
* Q3 EARNINGS PER SHARE VIEW $-0.55 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXnm1bW
Further company coverage: VINC.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign